The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd

Criteria

Inclusion criteria:

1. diagnosis of type 2 diabetes for more than one year.

2. the sustained follow-up time >3 month.

3. TNTL single or combined treatment time >3 month.

4. Chinese ethnicity.

Exclusion criteria:

1. the medical record information is not original and available.

2. lactating or pregnant.

3. diagnosis of heart failure, acute myocardial infarction, stroke, or serious injuries.

4. any other conditions not suitable for trial as evaluated by the physician in charge.